About
Paul Swartzendruber founded Elora Therapeutics to address one of the most overlooked threats to human health: microplastic accumulation in the body. With a background spanning early-stage product development and business, international policy, and now biotechnology commercialization, Paul brings a multidisciplinary lens to therapeutic innovation
Prior to launching Elora, Paul served as a Foreign Service Officer with the U.S. Department of State, where he oversaw chemical and biological weapons issues. Earlier in his career, he held roles in marketing and product strategy at VRBO, led marketing at a tech startup acquired by a major media platform, and co-founded a consumer hardware company. This uncommon blend of technical curiosity, operational rigor, and public health focus laid the groundwork for Elora’s mission to develop first-in-class enzyme therapeutics for systemic microplastic degradation.
He holds degrees from The University of Texas at Austin, University of Maryland University College, and Harvard University.
Joined
September 2025
